Title

Our Focus

We focus our efforts and resources where the need is high, the science is compelling and where we have the greatest opportunity to save and improve lives.

CP-346495 | September 2024

Infectious Diseases and Vaccines

Many of us have felt the consequences of infectious diseases, whether personally, through a family member or as a...

Oncology and Haematology

Despite the incredible work of the oncology community across Europe, cancer remains the second leading cause of...

Immunology

Janssen is committed to helping ease the battle that people living with immune-mediated inflammatory diseases have to...

Neuroscience

We want to reduce the burden, disability and devastation caused by serious neuropsychiatric and neurodegenerative...

Pulmonary Hypertension

In June 2017, Actelion became part of the Janssen Pharmaceutical Companies of Johnson & Johnson. In February 2019,...

Cardiovascular and Metabolic Diseases

Cardiovascular and metabolic diseases are a major threat to life for adults, accounting for millions of deaths...